東京女子医科大学 泌尿器科学教室・前立腺腫瘍センター 准教授
日本泌尿器科学会 泌尿器科専門医・泌尿器科指導医 日本がん治療認定医機構 がん治療認定医 日本泌尿器内視鏡・ロボティクス学会 泌尿器腹腔鏡技術認定者 日本内視鏡外科学会 技術認定取得者(泌尿器科領域) 日本透析医学会 透析専門医 日本移植学会 移植認定医 日本臨床腎移植学会 腎移植認定医 日本腎臓学会 会員 日本内分泌外科学会 会員
続きを読む
日本泌尿器科学会 | 泌尿器科専門医・泌尿器科指導医 |
---|---|
日本がん治療認定医機構 | がん治療認定医 |
日本泌尿器内視鏡・ロボティクス学会 | 泌尿器腹腔鏡技術認定者 |
日本内視鏡外科学会 | 技術認定取得者(泌尿器科領域) |
日本透析医学会 | 透析専門医 |
日本移植学会 | 移植認定医 |
日本臨床腎移植学会 | 腎移植認定医 |
日本腎臓学会 | 会員 |
日本内分泌外科学会 | 会員 |
東京女子医科大学病院
1997年
旭川医科大学医学部医学科
卒業
1998年
東京女子医科大学腎臓病総合医療センター泌尿器科
所属
2006年
博士号(東京女子医科大学)
取得
2008年
東京女子医科大学泌尿器科
助教
2012年
東京女子医科大学泌尿器科
医局長
2017年
東京女子医科大学泌尿器科
講師
Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging, Asia-Pacific Journal of Clinical Oncology, 2018 Nov;14 Suppl 5:16-23, DOI: 10.1111/ajco.13058
Iizuka J
Follow-up Survey of Donor Candidates for Living Related Kidney Transplantation with Prostate Cancer, Transplant Proc. 2018 Oct;50(8):2338-2341. doi: 10.1016/j.transproceed.2018.03.036. Epub 2018 Mar 16.PMID: 30316354
Hata K, Iizuka J, Hashimoto Y, Takagi T, Kondo T, Omoto K, Shimizu T, Okumi M, Inui M, Ishida H, Tanabe K,
Radical prostatectomy for localized prostate cancer in renal transplant recipients: 13 cases studied at a single center, Transplant Proc. 2018 Oct;50(8):2539-2544. doi: 10.1016/j.transproceed.2018.03.029. Epub 2018 Mar 15. PMID: 30316394
Iwamoto K, Iizuka J, Hashimoto Y, Kondo T, Takagi T, Hata K, Unagami K, Okumi M, Ishida H, Tanabe K
Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy, Clin Genitourin Cancer. 2018 Aug;16(4):e817-e829. doi: 10.1016/j.clgc.2018.02.011. Epub 2018 Feb 24.
Takeuchi N, Sakamoto S, Nishiyama A, Horikoshi T, Yamada Y, Iizuka J, Maimaiti M, Imamura Y, Kawamura K, Imamoto T, Komiya A, Ikehara Y, Akakura K, Ichikawa T
The 5-year outcomes of moderately hypofractionated radiotherapy (66 Gy in 22 fractions, 3 fractions per week) for localized prostate cancer: a retrospective study, Int J Clin Oncol. 2018 Feb;23(1):165-172.
Hashimoto Y, Motegi A, Akimoto T, Mitsuhashi N, Iizuka J, Tanabe K, Ishii Y, Kono S, Izumi S, Karasawa K
Incidental detection of asymptomatic migration of Hem-o-lok clip into the bladder after laparoscopic radical prostatectomy. Asian J Endosc Surg. 2017 Jun 15. doi: 10.1111/ases.12384. [Epub ahead of print] PMID: 28620946
Iizuka J, Hashimoto Y, Kondo T, Takagi T, Hata K, Kanzawa T, Tachibana H, Yoshida K, Tanabe K.
Robot-assisted Radical Prostatectomy for Localized Prostate Cancer in Asian Renal Transplant Recipients. Transplant Proc. 2016 Apr;48(3): 905-9. doi: 10.1016/j.transproceed.2016.01.036. PMID: 27234764
Iizuka J, Hashimoto Y, Kondo T, Takagi T, Inui M, Nozaki T, Omoto K, Shimizu T, Ishida H, Tanabe K.
Efficacy and Feasibility of Low-Dose Rate Brachytherapy for Prostate Cancer in Renal-Transplant Recipients. Transplant Proc. 2016 Apr;48(3):910-3. doi: 10.1016/j.transproceed.2016.01.031.PMID: 27234765
Iizuka J, Hashimoto Yas, Hashimoto Yai, Kondo T, Takagi T, Nozaki T, Shimizu T, Akimoto T, Ishida H, Karasawa K, Tanabe K
Efficacy and Feasibility of Intensity-Modulated Radiation Therapy for Prostate Cancer in Renal-Transplant Recipients. Transplant Proc. 2016 Apr;48(3):914-7. doi: 10.1016/j.transproceed.2016.01.032. PMID: 27234766
Iizuka J, Hashimoto Yas, Hashimoto Yai, Kondo T, Takagi T, Nozaki T, Shimizu T, Akimoto T, Ishida H, Karasawa K, Tanabe K.
Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for prostate cancer. Jpn J Clin Oncol. 2015 Jan;45(1):81-7. doi: 10.1093/jjco/hyu173. Epub 2014 Nov 24. PubMed PMID: 25425700.
Hashimoto Y, Akimoto T, Iizuka J, Tanabe K, Mitsuhashi N.
Management of Localized Prostate Cancer by Retroperitoneal Laparoscopic Radical Prostatectomy in Patients after Kidney Transplantation, Int J Nephrol Kidney Failure 2015 1(3)
Inui M, Iizuka J, Hashimoto Y, Takagi T, Okumi M, Kondo T, Ishida H, Tanabe K
Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma. Int J Urol. 2012 Nov;19(11):980-6. doi: 10.1111/j.1442-2042.2012.03085.x. Epub 2012 Jun 26. PubMed PMID: 22735049.
Iizuka J*, Kondo T, Hashimoto Y, Kobayashi H, Ikezawa E, Takagi T, Omae K, Tanabe K.
Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-assisted Partial Nephrectomy. J Endourol. 2018 Aug 24. doi: 10.1089/end.2017.0779. [Epub ahead of print], PMID: 30141346
Ishiyama R, Kondo T, Takagi T, Iizuka J, Kobayashi H, Omae K, Fukuda H, Ishihara H, Tanabe K.
Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma. Jpn J Clin Oncol. 2018 Aug 3. doi: 10.1093/jjco/hyy106. [Epub ahead of print] PMID: 30113653
Takagi T, Yoshida K, Kobayashi H, Kondo T, Iizuka J, Okumi M, Ishida H, Fukuda H, Ishihara H, Tanabe K.
Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma. Jpn J Clin Oncol. 2018 Jul 1;48(7):667-672. doi: 10.1093/jjco/hyy078. PMID: 29860353
Ishihara H, Takagi T, Kondo T, Iwamoto K, Tachibana H, Yoshida K, Omae K, Iizuka J, Kobayashi H, Tanabe K.
Prognostic Impact of the Components of Progressive Disease on Survival After First-Line Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma. Target Oncol. 2018 Jun;13(3):379-387. doi: 10.1007/s11523-018-0569-y. PMID: 29785576
Ikeda T, Ishihara H, Takagi T, Kondo T, Yoshida K, Iizuka J, Tanabe K.
Evaluation of relative dose intensity during the early phase of first-line sunitinib treatment using a 2-week-on/1-week-off regimen for metastatic renal cell carcinoma. Med Oncol. 2018 Apr 23;35(6):78. doi: 10.1007/s12032-018-1139-y. PMID: 29687160
Iwamoto K, Ishihara H, Takagi T, Kondo T, Yoshida K, Iizuka J, Tanabe K.
Outcome of the risk-stratified desensitization protocol in donor-specific antibody-positive living kidney transplant recipients: a retrospective study. Transpl Int. 2018 Apr 20. doi: 10.1111/tri.13269. [Epub ahead of print] PMID: 29676803
Okada D, Okumi M, Kakuta Y, Unagami K, Iizuka J, Takagi T, Ishida H, Tanabe K.
Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy. Int J Clin Oncol. 2018 Jun;23(3):559-567. doi: 10.1007/s10147-018-1241-3. Epub 2018 Jan 11. PMID: 29327159
Ishihara H, Takagi T, Kondo T, Tachibana H, Yoshida K, Omae K, Iizuka J, Kobayashi H, Tanabe K.
Japan Academic Consortium of Kidney Transplantation. Cardiovascular disease in kidney transplant recipients: Japan Academic Consortium of Kidney Transplantation (JACK) cohort study. Clin Exp Nephrol. 2018 Jun;22(3):702-709. doi: 10.1007/s10157-017-1500-z. Epub 2017 Nov 20. PMID: 29159526
Okumi M, Kakuta Y, Unagami K, Maenosono R, Miyake K, Iizuka J, Takagi T, Ishida H, Tanabe K
Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma. Jpn J Clin Oncol. 2017 Dec 1;47(12):1175-1181. doi: 10.1093/jjco/hyx161. PMID: 29140528
Ishihara H, Kondo T, Fukuda H, Yoshida K, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K.
The 5-year outcomes of moderately hypofractionated radiotherapy (66 Gy in 22 fractions, 3 fractions per week) for localized prostate cancer: a retrospective study. Int J Clin Oncol. 2018 Feb;23(1):165-172. doi: 10.1007/s10147-017-1175-1. Epub 2017 Jul 31. PMID: 28758177
Hashimoto Y, Motegi A, Akimoto T, Mitsuhashi N, Iizuka J, Tanabe K, Ishii Y, Kono S, Izumi S, Karasawa K.
Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy. Urol Oncol. 2017 Jun 12. pii: S1078-1439(17)30231-4. doi: 10.1016/j.urolonc.2017.05.014. [Epub ahead of print] PMID: 28619633
Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K.
Comparison of Surgical Outcomes Between Resection and Enucleation in Robot-Assisted Laparoscopic Partial Nephrectomy for Renal Tumors According to the Surface-Intermediate-Base Margin Score: A Propensity Score-Matched Study. J Endourol. 2017 Jun 20. doi: 10.1089/end.2017.0260. [Epub ahead of print] PMID: 28537438
Takagi T, Kondo T, Tachibana H, Iizuka J, Omae K, Yoshida K, Kobayashi H, Okumi M, Ishida H, Tanabe K.
Surgical and Oncologic Outcomes of Laparoscopic Radical Nephrectomy for Non-Metastatic Renal Cancer in Long-Term Dialysis Patients. Ther Apher Dial. 2017 Jan 9. doi: 10.1111/1744-9987.12500. [Epub ahead of print] PMID: 28067459
Omae K, Kondo T, Takagi T, Iizuka J, Kobayashi H, Hashimoto Y, Tanabe K.
Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinoma. Jpn J Clin Oncol. 2016 Dec 27. doi: 10.1093/jjco/hyw196. [Epub ahead of print] PMID: 28031355
Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K.
Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy. Int J Clin Oncol. 2016 Aug 22. [Epub ahead of print] PMID: 27549785
Ishihara H, Yagisawa T, Kondo T, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K.
Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer. Int J Clin Oncol. 2016 Jul 23. [Epub ahead of print] PMID: 27450420
Kondo T, Hara I, Takagi T, Kodama Y, Hashimoto Y, Kobayashi H, Iizuka J, Omae K, Yoshida K, Tanabe K.
Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study. Int J Clin Oncol. 2016 Jul 15. [Epub ahead of print] PMID: 27422388
Ishihara H, Kondo T, Omae K, Takagi T, Iizuka J, Kobayashi H, Hashimoto Y, Tanabe K.
Late recurrence of a malignant hypoglycemia-inducing pelvic solitary fibrous tumor secreting high-molecular-weight insulin-like growth factor-II: A case report with protein analysis. Oncol Lett. 2016 Jul;12(1):479-484. PMID: 27347168
Ishihara H, Omae K, Iizuka J, Kobayashi H, Fukuda I, Kondo T, Hizuka N, Nagashima Y, Tanabe K.
A propensity score-matched comparison of surgical precision obtained by using volumetric analysis between robot-assisted laparoscopic and open partial nephrectomy for T1 renal cell carcinoma: a retrospective non-randomized observational study of initial outcomes. Int Urol Nephrol. 2016 Oct;48(10):1585-91. doi: 10.1007/s11255-016-1323-y. PMID: 27262849
Takagi T, Kondo T, Tachibana H, Iizuka J, Omae K, Kobayashi H, Yoshida K, Hashimoto Y, Tanabe K.
【共著】腎癌のすべて 改訂第2版.飯塚淳平 田邉一成 進行腎癌症例:心房内腫瘍血栓合併症,第1刷,356-358.メジカルビュー社.
【部分執筆】泌尿器科手術における血管外科.飯塚淳平 田邉一成.前立腺全摘除術と膀胱全摘除術 開腹手術.1,1,123-134.メジカルビュー社.
【部分執筆】泌尿器科手術における血管外科.飯塚淳平 田邉一成.前立腺全摘除術と膀胱全摘除術 腹腔鏡・後腹膜腔鏡手術.1,1,135-150.メジカルビュー社.
【部分執筆】泌尿器科手術における血管外科.飯塚淳平 田邉一成.血管外科の基本手技 主要血管と手技 骨盤内の血管.1,1,65-75.メジカルビュー社.
【受賞】2009年 第74回日本泌尿器科学会東部総会 Best Poster賞
【受賞】2015年 14th Congress of the Asian Society of Transplantation. Best Poster Award
本ページにおける情報は、医師本人の申告に基づいて掲載しております。内容については弊社においても可能な限り配慮しておりますが、最新の情報については公開情報等をご確認いただき、またご自身でお問い合わせいただきますようお願いします。
なお、弊社はいかなる場合にも、掲載された情報の誤り、不正確等にもとづく損害に対して責任を負わないものとします。